Lifetech Scientific Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
1,392
- Stock Symbol
-
01302
- Investments
-
6
- Share Price
-
$0.22
- (As of Monday Closing)
Lifetech Scientific General Information
Description
LifeTech Scientific Corp develops and manufactures also responsible for marketing of of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of its revenue from China.
Contact Information
Website
www.lifetechmed.comCorporate Office
- Lifetech Scientific Building, NO.22, Keji 12th Road South
- Hi-tech Industrial Park, Nanshan District
- Shenzhen, 518057
- China
Corporate Office
- Lifetech Scientific Building, NO.22, Keji 12th Road South
- Hi-tech Industrial Park, Nanshan District
- Shenzhen, 518057
- China
Lifetech Scientific Stock Performance
As of 14-Jul-2025, Lifetech Scientific’s stock price is $0.22. Its current market cap is $964M with 4.4B shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.22 | $0.22 | $0.16 - $0.27 | $964M | 4.4B | 32.7M |
Lifetech Scientific Financials Summary
As of 31-Dec-2024, Lifetech Scientific has a trailing 12-month revenue of $182M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 654,358 | 654,358 | 1,260,795 | 1,327,008 |
| Revenue | 181,689 | 181,689 | 179,109 | 162,938 |
| EBITDA | 35,847 | 35,847 | 31,826 | 62,000 |
| Net Income | 30,993 | 30,993 | 37,208 | 48,309 |
| Total Assets | 671,275 | 671,275 | 662,523 | 534,852 |
| Total Debt | 682 | 682 | 1,311 | 1,402 |
Lifetech Scientific Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lifetech Scientific Patents
Lifetech Scientific Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4458326-A1 | Endoluminal stent | Pending | 31-Dec-2021 | ||
| EP-4458326-A4 | Endoluminal stent | Pending | 31-Dec-2021 | ||
| EP-4458327-A1 | Lumen stent | Pending | 31-Dec-2021 | ||
| EP-4458327-A4 | Lumen stent | Pending | 31-Dec-2021 | ||
| US-20250057671-A1 | Lumen stent | Pending | 31-Dec-2021 | A61F2/07 |
Lifetech Scientific Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lifetech Scientific Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lifetech Scientific Investments (6)
Lifetech Scientific’s most recent deal was a Early Stage VC with Jianhu Medical for . The deal was made on 09-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jianhu Medical | 09-Jun-2025 | Early Stage VC | Diagnostic Equipment | ||
| Jenscare Biotechnology | 10-Oct-2022 | IPO | Therapeutic Devices | ||
| Shenzhen Yunma Biotechnology | 04-Jun-2019 | Joint Venture | Pharmaceuticals | ||
| China Joint Venture (Ally Bridge Group / LifeTech Scientific Corporation / Quantum Surgical) | 03-Apr-2019 | Joint Venture | Surgical Devices | ||
| GRAIL | 21-May-2018 | Later Stage VC | Biotechnology |
Lifetech Scientific ESG
Risk Overview
Risk Rating
Updated August, 08, 2024
31.41 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile
Healthcare
Industry
of 562
Rank
Percentile
Medical Devices
Subindustry
of 194
Rank
Percentile
Lifetech Scientific Exits (2)
Lifetech Scientific’s most recent exit was on 21-May-2018 from GRAIL. The exit was categorized as with 12 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| GRAIL | 21-May-2018 | Completed |
|
||
| Broncus Medical | 06-Jun-2012 | Later Stage VC | Completed |
|
Lifetech Scientific Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Biotyx Medical | Shenzhen, China | 2019 |
Lifetech Scientific FAQs
-
When was Lifetech Scientific founded?
Lifetech Scientific was founded in 1999.
-
Where is Lifetech Scientific headquartered?
Lifetech Scientific is headquartered in Shenzhen, China.
-
What is the size of Lifetech Scientific?
Lifetech Scientific has 1,392 total employees.
-
What industry is Lifetech Scientific in?
Lifetech Scientific’s primary industry is Surgical Devices.
-
Is Lifetech Scientific a private or public company?
Lifetech Scientific is a Public company.
-
What is Lifetech Scientific’s stock symbol?
The ticker symbol for Lifetech Scientific is 01302.
-
What is the current stock price of Lifetech Scientific?
As of 14-Jul-2025 the stock price of Lifetech Scientific is $0.22.
-
What is the current market cap of Lifetech Scientific?
The current market capitalization of Lifetech Scientific is $964M.
-
What is Lifetech Scientific’s current revenue?
The trailing twelve month revenue for Lifetech Scientific is $182M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
